Acutaas Chemicals to Attend Investor Conference Meets on Feb 21 & 24
Acutaas Chemicals Limited will attend the Ombkara Capital Investors Meet on February 21, 2026, and the Kotak Flagship Conference "Chasing Growth 2026" on February 24, 2026. Officials will engage in investor and analyst meetings. No price-sensitive information will be discussed.
This is a routine disclosure about upcoming investor interactions and does not involve any material new information or significant business developments.
The announcement is an intimation of investor meetings and does not contain any financial results or specific business updates that would sway sentiment.
Acutaas Chemicals Limited (formerly Ami Organics Limited) has announced its participation in upcoming investor conferences. The company's officials will engage in one-on-one and group meetings with investors and analysts.
The first interaction is scheduled for February 21, 2026, at the Ombkara Capital Investors Meet in Mumbai. This will be followed by participation in the Kotak Flagship Conference "Chasing Growth 2026" on February 24, 2026, also in Mumbai, where similar one-on-one and group meetings will take place.
Acutaas Chemicals has stated that no unpublished price-sensitive information will be disclosed during these interactions. The schedule is subject to change.
What to do with a filing like this
Acutaas Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under investor meet intimation. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Acutaas Chemicals Limited. Read the original for the full detail.